blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2287306

EP2287306 - RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  09.09.2016
Database last updated on 31.08.2024
Most recent event   Tooltip09.09.2016Patent maintained (B2 publication)published on 12.10.2016  [2016/41]
Applicant(s)For all designated states
Sirna Therapeutics, Inc.
300 Third Street
Cambridge MA 02142 / US
[2014/17]
Former [2011/08]For all designated states
Sirna Therapeutics, Inc.
2950 Wilderness Place
Boulder, CO 80301 / US
Inventor(s)01 / Mcswiggen, James
4866 Franklin Drive
Boulder, CO 80301 / US
02 / Beigelman, Leonid
5530 Colt Drive
Longmont, CO 80503 / US
03 / Chowrira, Bharat
576 Manorwood Lane
Louisville, CO 80027 / US
04 / Pavco, Pamela
705 Barberry Circle
Lafayette, CO 80026 / US
05 / Fosnaugh, Kathy
1030 Edinboro Drive
Boulder, CO 80305 / US
06 / Jamison, Sharon
4985 Twin Lakes Rd 89
Boulder, CO 80301 / US
07 / Usman, Nassim
2129 Night Sky Lane
Lafayette, CO 80026 / US
08 / Thompson, James
705 Barberry Circle
Lafayette, CO 80026 / US
 [2011/08]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2016/41]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Former [2014/17]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham, NG1 5GG / GB
Former [2011/08]Hussain, Deeba, et al
Merck Sharp & Dohme Limited Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Application number, filing date10008930.920.02.2003
[2011/08]
Priority number, dateUS20020358580P20.02.2002         Original published format: US 358580 P
US20020363124P11.03.2002         Original published format: US 363124 P
US20020386782P06.06.2002         Original published format: US 386782 P
US20020406784P29.08.2002         Original published format: US 406784 P
US20020408378P05.09.2002         Original published format: US 408378 P
US20020409293P09.09.2002         Original published format: US 409293 P
US20030440129P15.01.2003         Original published format: US 440129 P
[2011/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2287306
Date:23.02.2011
Language:EN
[2011/08]
Type: B1 Patent specification 
No.:EP2287306
Date:22.08.2012
Language:EN
[2012/34]
Type: B2 New European patent specification 
No.:EP2287306
Date:12.10.2016
Language:EN
[2016/41]
Search report(s)(Supplementary) European search report - dispatched on:EP03.01.2011
ClassificationIPC:C12N15/113, A61K31/713
[2011/08]
CPC:
C12N15/8218 (EP,US); A61K47/54 (EP,US); A61P1/00 (EP);
A61P1/04 (EP); A61P1/16 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P13/08 (EP); A61P13/10 (EP);
A61P13/12 (EP); A61P15/00 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P19/00 (EP); A61P19/02 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P25/02 (EP);
A61P25/08 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P27/16 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/10 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P31/10 (EP);
A61P31/12 (EP); A61P31/14 (EP); A61P31/16 (EP);
A61P31/18 (EP); A61P31/20 (EP); A61P31/22 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/00 (EP);
A61P37/04 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P41/00 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07H21/02 (EP,US);
C12N15/111 (EP,US); C12N15/1131 (EP,US); C12N15/1138 (EP,US);
A61K38/00 (EP,US); C12N2310/111 (EP,US); C12N2310/14 (EP,US);
C12N2310/315 (EP,US); C12N2310/317 (EP,US); C12N2310/318 (EP,US);
C12N2310/321 (EP,US); C12N2310/322 (EP,US); C12N2310/332 (EP,US);
C12N2310/344 (EP,US); C12N2310/346 (EP,US); C12N2310/53 (EP,US);
C12N2320/51 (EP,US); C12N2330/30 (EP,US); Y02A50/30 (EP,US) (-)
C-Set:
C12N2310/321, C12N2310/3521 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2016/41]
Former [2011/08]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  SI,  SK,  TR 
TitleGerman:RNA-Interferenz-vermittelte Inhibition von Genexpression unter Verwendung kurzer interferierender Nukleinsäure (siNA)[2011/08]
English:RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)[2011/08]
French:Inhibition au moyen d'interférence ARN d'une expression de gène utilisant un acide nucléique à petit interférent (siNA)[2011/08]
Examination procedure23.08.2011Examination requested  [2011/40]
05.10.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
13.12.2011Amendment by applicant (claims and/or description)
17.02.2012Communication of intention to grant the patent
20.06.2012Fee for grant paid
20.06.2012Fee for publishing/printing paid
Parent application(s)   TooltipEP03743684.7  / EP1423406
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030743684) is  25.07.2005
Opposition(s)Opponent(s)01  22.05.2013  05.06.2013  ADMISSIBLE
Quark Pharmaceuticals, Inc.
6501 Dumbarton Circle
Fremont, California 94555 / US
Opponent's representative
Almond-Martin, Carol, et al, et al
Ernest Gutmann - Yves Plasseraud S.A.S. 88, Boulevard des Belges
69452 Lyon Cedex 06 / FR
 02  21.05.2013  10.03.2014  WITHDRAWN
Alnylam Pharmaceuticals Inc.
300 Third street, Third Floor
Cambridge MA 02142 / US
Opponent's representative
Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
 [N/P]
Former [2014/16]
Opponent(s)01  22.05.2013  05.06.2013  ADMISSIBLE
Quark Pharmaceuticals, Inc.
6501 Dumbarton Circle
Fremont, California 94555 / US
Opponent's representative
Almond-Martin, Carol, et al, et al
Ernest Gutmann - Yves Plasseraud S.A.S. 88, Boulevard des Belges
69452 Lyon Cedex 06 / FR
 02  21.05.2013  10.03.2014  WITHDRAWN
Alnylam Pharmaceuticals Inc.
300 Third street, Third Floor
Cambridge MA 02142 / US
Opponent's representative
Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
Former [2014/13]
Opponent(s)01  22.05.2013  05.06.2013  ADMISSIBLE
Quark Pharmaceuticals, Inc.
6501 Dumbarton Circle
Fremont, California 94555 / US
Opponent's representative
Almond-Martin, Carol, et al, et al
Ernest Gutmann - Yves Plasseraud S.A.S. 88, Boulevard des Belges
69452 Lyon Cedex 06 / FR
 02  21.05.2013  28.05.2013  ADMISSIBLE
Alnylam Pharmaceuticals Inc.
300 Third street, Third Floor
Cambridge MA 02142 / US
Opponent's representative
Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
Former [2014/12]
Opponent(s)01  22.05.2013  05.06.2013  ADMISSIBLE
Quark Pharmaceuticals, Inc.
6501 Dumbarton Circle
Fremont, California 94555 / US
Opponent's representative
Sellin, Carole, et al, et al
Ernest Gutmann - Yves Plasseraud S.A.S 88, Boulevard des Belges
69452 Lyon Cedex 06 / FR
 02  21.05.2013  28.05.2013  ADMISSIBLE
Alnylam Pharmaceuticals Inc.
300 Third street, Third Floor
Cambridge MA 02142 / US
Opponent's representative
Müller-Boré & Partner Patentanwälte PartG mbB
Grafinger Straße 2
81671 München / DE
Former [2013/26]
Opponent(s)01  22.05.2013   
Quark Pharmaceuticals, Inc.
6501 Dumbarton Circle
Fremont, California 94555 / US
Opponent's representative
Sellin, Carole, et al, et al
Ernest Gutmann - Yves Plasseraud S.A.S 88, Boulevard des Belges
69452 Lyon Cedex 06 / FR
 02  21.05.2013   
Alnylam Pharmaceuticals Inc.
300 Third street, Third Floor
Cambridge MA 02142 / US
Opponent's representative
Lenhard, Konstanze
Müller-Boré & Partner Grafinger Straße 2
81671 München / DE
17.06.2013Invitation to proprietor to file observations on the notice of opposition
24.12.2013Reply of patent proprietor to notice(s) of opposition
25.11.2015Legal effect of interlocutory decision in opposition
25.11.2015Date of oral proceedings
28.01.2016Despatch of minutes of oral proceedings
17.02.2016Despatch of interlocutory decision in opposition
02.06.2016Despatch of communication that the patent will be maintained as amended
01.09.2016Fee for printing new specification paid
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
13.12.2011Request for further processing filed
13.12.2011Full payment received (date of receipt of payment)
Request granted
23.12.2011Decision despatched
Fees paidRenewal fee
27.12.2010Renewal fee patent year 03
27.12.2010Renewal fee patent year 04
27.12.2010Renewal fee patent year 05
27.12.2010Renewal fee patent year 06
27.12.2010Renewal fee patent year 07
27.12.2010Renewal fee patent year 08
08.02.2011Renewal fee patent year 09
07.02.2012Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.02.2003
CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
TR22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
LU20.02.2013
MC28.02.2013
AT20.02.2014
FI20.02.2014
IE20.02.2014
IT20.02.2014
ES21.02.2014
SE21.02.2014
BE28.02.2014
DK28.02.2014
[2016/33]
Former [2016/29]HU20.02.2003
CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
TR22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
LU20.02.2013
MC28.02.2013
AT20.02.2014
FI20.02.2014
IE20.02.2014
IT20.02.2014
SE21.02.2014
BE28.02.2014
DK28.02.2014
Former [2015/34]HU20.02.2003
CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
TR22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
LU20.02.2013
MC28.02.2013
AT20.02.2014
FI20.02.2014
IE20.02.2014
SE21.02.2014
BE28.02.2014
DK28.02.2014
Former [2015/32]CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
TR22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
MC28.02.2013
AT20.02.2014
FI20.02.2014
IE20.02.2014
SE21.02.2014
BE28.02.2014
DK28.02.2014
Former [2015/08]CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
MC28.02.2013
AT20.02.2014
FI20.02.2014
IE20.02.2014
SE21.02.2014
BE28.02.2014
DK28.02.2014
Former [2015/07]CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
MC28.02.2013
AT20.02.2014
FI20.02.2014
IE20.02.2014
SE21.02.2014
Former [2014/51]CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
MC28.02.2013
AT20.02.2014
FI20.02.2014
SE21.02.2014
Former [2014/50]CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
MC28.02.2013
FI20.02.2014
SE21.02.2014
Former [2014/49]CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
MC28.02.2013
FI20.02.2014
Former [2013/52]CY22.08.2012
CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
MC28.02.2013
Former [2013/42]CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
MC28.02.2013
Former [2013/34]CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
BG22.11.2012
GR23.11.2012
PT24.12.2012
Former [2013/23]CZ22.08.2012
EE22.08.2012
SI22.08.2012
SK22.08.2012
GR23.11.2012
PT24.12.2012
Former [2013/22]CZ22.08.2012
EE22.08.2012
SI22.08.2012
GR23.11.2012
PT24.12.2012
Former [2013/13]SI22.08.2012
GR23.11.2012
PT24.12.2012
Former [2013/11]SI22.08.2012
GR23.11.2012
Documents cited:Search[A]WO0136646  (CANCER RES CAMPAIGN TECH [GB], et al) [A] 1-27* page 6, line 29 - page 7, line 8 *;
 [A]  - ELBASHIR S M ET AL, Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate, EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, PAGE(S) 6877 - 6888, (20011203), ISSN 0261-4189, XP002225998 [A] 1-27 * page 6881, column r, paragraph 2 - page 6882, column l, paragraph 1 * * figure 4 *

DOI:   http://dx.doi.org/10.1093/emboj/20.23.6877
 [A]  - PARRISH S ET AL, Functional anatomy of a dsRNA trigger: Differential requirement for the two trigger strands in RNA interference, MOLECULAR CELL, CELL PRESS, CAMBRIDGE, MA, US, PAGE(S) 1077 - 1087, (20001101), ISSN 1097-2765, XP002226298 [A] 1-27 * page 1081, column l, paragraph 1 - column r, paragraph 4 * * figure 5 *

DOI:   http://dx.doi.org/10.1016/S1097-2765(00)00106-4
 [A]  - BASS B L, RNA interference: the short answer, NATURE, NATURE PUBLISHING GROUP, LONDON, GB, PAGE(S) 428 - 429, (20010524), ISSN 0028-0836, XP002239989 [A] 1-27 * page 428, column r, paragraph 3 - page 429, column l, paragraph 1 *

DOI:   http://dx.doi.org/10.1038/35078175
by applicantWO8902439
 WO9103162
 WO9207065
 WO9315187
 WO9323569
 WO9402595
 US5334711
 WO9506731
 WO9511910
 WO9610391
 WO9610390
 WO9610392
 WO9618736
 US5624803
 US5627053
 US5631360
 WO9726270
 US5672695
 US5716824
 WO9813526
 US5804683
 US5831071
 US5854038
 WO9905094
 WO9904819
 WO9907409
 WO9914226
 US5889136
 US5902880
 WO9931262
 WO9932619
 WO9949029
 WO9953050
 WO9954459
 US5998203
 US6001311
 US6008400
 WO0001846
 US6054576
 WO0044914
 CA2359180
 WO0044895
 US6111086
 US6117657
 WO0053722
 WO0063364
 WO0066604
 US6146886
 US6162909
 WO0104313
 WO0129058
 WO0136646
 WO0138551
 WO0142443
 US6248878
 WO0149844
 WO0153475
 WO0168836
 WO0170944
 WO0170949
 AU4037501
 WO0172774
 US6300074
 WO0175164
 US6303773
 WO0192513
 US6353098
 US6362323
 WO0238805
 US6395713
 WO0244321
 WO02055692
 WO02055693
 US6437117
 EP1144623
 US6469158
 US6506559
    - FIRE ET AL., NATURE, (1998), vol. 391, page 806
    - FIRE ET AL., TRENDS GENET., (1999), vol. 15, page 358
    - BERSTEIN ET AL., NATURE, (2001), vol. 409, page 363
    - ELBASHIR ET AL., GENES DEV., (2001), vol. 15, page 188
    - HUTVAGNER ET AL., SCIENCE, (2001), vol. 293, page 834
    - WIANNY; GOETZ, NATURE CELL BIOL., (1999), vol. 2, page 70
    - HAMMOND ET AL., NATURE, (2000), vol. 404, page 293
    - ELBASHIR ET AL., NATURE, (2001), vol. 411, page 494
    - ELBASHIR ET AL., EMBO J., (2001), vol. 20, page 6877
    - NYKANEN ET AL., CELL, (2001), vol. 107, page 309
    - PARRISH ET AL., MOLECULAR CELL, (2000), vol. 6, pages 1977 - 1087
    - TUSCHL, CHEM. BIOCHEM., (2001), vol. 2, pages 239 - 245
    - GOLD ET AL., ANNU. REV. BIOCHEM., (1995), vol. 64, page 763
    - BRODY; GOLD, J. BIOTECHNOL., (2000), vol. 74, page 5
    - SUN, CURR. OPIN. MOL THER., (2000), vol. 2, page 100
    - KUSSER, J. BIOTECHNOL., (2000), vol. 74, page 27
    - HERMANN; PATEL, SCIENCE, (2000), vol. 287, page 820
    - JAYASENA, CLINICAL CHEMISTRY, (1999), vol. 45, page 1628
    - SEELA; KAISER, NUCLEIC ACIDS RES., (1990), vol. 18, page 6353
    - NUCLEIC ACIDS RES., (1987), vol. 15, page 3113
    - CLOAD; SCHEPARTZ, J. AM. CHEM. SOC., (1991), vol. 113, page 6324
    - RICHARDSON; SCHEPARTZ, J AM. CHEM. SOC., (1991), vol. 113, page 5109
    - MA ET AL., NUCLEIC ACIDS RES., (1993), vol. 21, page 2585
    - BIOCHEMISTRY, (1993), vol. 32, page 1751
    - DURAND ET AL., NUCLEIC ACIDS RES., (1990), vol. 18, page 6353
    - MCCURDY ET AL., NUCLEOSIDES & NUCLEOTIDES, (1991), vol. 10, page 287
    - JSCHKE ET AL., TETRAHEDRON LETT., (1993), vol. 34, page 301
    - ONO ET AL., BIOCHEMISTRV, (1991), vol. 30, page 9914
    - FERENTZ; VERDINE, J. AM. CHEM. SOC., (1991), vol. 113, page 4000
    - BASS, NATURE, (2001), vol. 411, pages 428 - 429
    - ELBASHIR, NATURE, (2001), vol. 411, pages 494 - 498
    - ALLSHIRE, SCIENCE, (2002), vol. 297, pages 1818 - 1819
    - VOLPE, SCIENCE, (2002), vol. 297, pages 1833 - 1837
    - JENUWEIN, SCIENCE, (2002), vol. 297, pages 2215 - 2218
    - HALL ET AL., SCIENCE, (2002), vol. 297, pages 2232 - 2237
    - HUTVAGNER; ZAMORE, SCIENCE, (2002), vol. 297, pages 2056 - 60
    - MCMANUS ET AL., RNA, (2002), vol. 8, pages 842 - 850
    - REINHART ET AL., GENE & DEV., (2002), vol. 16, pages 1616 - 1626
    - REINHART; BARTEL, SCIENCE, (2002), vol. 297, page 1831
    - MARTINEZ ET AL., CELL, (2002), vol. 110, pages 563 - 574
    - SCHWARZ ET AL., MOLECULAR CELL, (2002), vol. 10, pages 537 - 568
    - VOLPE ET AL., SCIENCE, (2002), vol. 297, pages 1833 - 1837
    - TURNER ET AL., CSH SYMP. QUANT. BIOL., (1987), vol. LII, pages 123 - 133
    - FRIER ET AL., PROC. NAT. ACAD. SCI. USA, (1986), vol. 83, pages 9373 - 9377
    - TURNER ET AL., J. AM. CHEM. SOC., (1987), vol. 109, pages 3783 - 3785
    - LOAKES, NUCLEIC ACIDS RESEARCH, (2001), vol. 29, pages 2437 - 2447
    - PAUL ET AL., NATURE BIOTECHNOLOGY, (2002), vol. 19, page 505
    - MIYAGISHI; TAIRA, NATURE BIOTECHNOLOGY, (2002), vol. 19, page 497
    - LEE ET AL., NATURE BIOTECHNOLOGY, (2002), vol. 19, page 500
    - ELBASHIR, NATURE, (2001), vol. 411, page 494
    - CARUTHERS ET AL., METHODS IN ENZYMOLOGY, (1992), vol. 211, pages 3 - 19
    - WINCOTT ET AL., NUCLEIC ACIDS RES., (1995), vol. 23, pages 2677 - 2684
    - WINCOTT ET AL., METHODS MOL. BIO., (1997), vol. 74, page 59
    - BRENNAN ET AL., BIOTECHNOL BIOENG., (1998), vol. 61, pages 33 - 45
    - USMAN ET AL., J. AM. CHEM. SOC., (1987), vol. 109, page 7845
    - SCARINGE ET AL., NUCLEIC ACIDS RES., (1990), vol. 18, page 5433
    - MOORE ET AL., SCIENCE, (1992), vol. 256, page 9923
    - SHABAROVA ET AL., NUCLEIC ACIDS RESEARCH, (1991), vol. 19, page 4247
    - BELLON ET AL., NUCLEOSIDES & NUCLEOTIDES, (1997), vol. 16, page 951
    - BELLON ET AL., BIOCONJUGATE CHEM., (1997), vol. 8, page 204
    - USMAN; CEDERGREN, TIBS, (1992), vol. 17, page 34
    - USMAN ET AL., NUCLEIC ACIDS SYMP. SER., (1994), vol. 31, page 163
    - PERRAULT ET AL., NATURE, (1990), vol. 344, page 565
    - PIEKEN ET AL., SCIENCE, (1991), vol. 253, page 314
    - USMAN; CEDERGREN, TRENDS IN BIOCHEM. SCI., (1992), vol. 17, page 334
    - USMAN; CEDERGREN, TIBS., (1992), vol. 17, page 34
    - BURGIN ET AL., BIOCHEMISTRY, (1996), vol. 35, page 14090
    - PERRAULT ET AL., NATURE, (1990), vol. 344, pages 565 - 568
    - PIEKEN, SCIENCE, (1991), vol. 253, pages 314 - 317
    - USMAN; CEDERGREN, TRENDS IN BIOCHEM. SCI., (1992), vol. 17, pages 334 - 339
    - BEIGELMAN ET AL., J. BIOL. CHEM., (1995), vol. 270, page 25702
    - KARPEISKY ET AL., TETRAHEDRON LETT., (1998), vol. 39, page 1131
    - EARNSHAW; GAIT, BIOPOLYMERS (NUCLEIC ACID SCIENCES), (1998), vol. 48, pages 39 - 55
    - VERMA; ECKSTEIN, ANNU. REV. BIOCHEM., (1998), vol. 67, pages 99 - 134
    - BURLINA ET AL., BIOORG. MED. CHEM., (1997), vol. 5, pages 1999 - 2010
    - WINCOTT ET AL., NUCLEIC ACIDS RES., (1995), vol. 23, page 2677
    - LIN; MATTEUCCI, J. AM. CHEM. SOC., (1998), vol. 120, pages 8531 - 8532
    - BEAUCAGE; IYER, TETRAHEDRON, (1993), vol. 49, page 1925
    - LIMBACH ET AL., NUCLEIC ACIDS RES., (1994), vol. 22, page 2183
    - "Nucleic Acid Analogues: Synthesis and Properties", HUNZIKER; LEUMANN, Modern Synthetic Methods, VCH, (1995), pages 331 - 417
    - "Novel Backbone Replacements for Oligonucleotides", MESMAEKER ET AL., Carbohydrate Modifications in Antisense Research, ACS, (1994), pages 24 - 39
    - AKHTAR ET AL., TRENDS CELL BIO., (1992), vol. 2, page 139
    - MAURER ET AL., MOL. MEMBR. BIOL., (1999), vol. 16, pages 129 - 140
    - HOFLAND; HUANG, HANDB. EXP. PHARMACOL., (1999), vol. 137, pages 165 - 192
    - LEE ET AL., ACS SYMP. SER., (2000), vol. 752, pages 184 - 192
    - GONZALEZ ET AL., BIOCONJUGATE CHEM., (1999), vol. 10, pages 1068 - 1074
    - CONRY ET AL., CLIN. CANCER RES., (1999), vol. 5, pages 2330 - 2337
    - CHUN ET AL., NEUROSCIENCE LETTERS, (1998), vol. 257, pages 135 - 138
    - D'ALDIN ET AL., MOL. BRAIN RESEARCH, (1998), vol. 55, pages 151 - 164
    - DRYDEN ET AL., J. ENDOCRINOL., (1998), vol. 157, pages 169 - 175
    - GHIRNIKAR ET AL., NEUROSCIENCE LETTERS, (1998), vol. 247, pages 21 - 24
    - GOLD, NEUROSCIENCE, (1997), vol. 76, pages 1153 - 1158
    - HARTMANN ET AL., J. PHAMACOL. EXP. THER., (1998), vol. 285, no. 2, pages 920 - 928
    - KRONENWETT ET AL., BLOOD, (1998), vol. 91, no. 3, pages 852 - 862
    - FILION; PHILLIPS, BIOCHIM. BIOPHYS. ACTA, (1997), vol. 1329, no. 2, pages 345 - 356
    - MA; WEI, LEUK. RES., (1996), vol. 20, no. 11/12, pages 925 - 930
    - BONGARTZ ET AL., NUCLEIC ACIDS RESEARCH, (1994), vol. 22, no. 22, pages 4681 - 8
    - JOLLIET-RIANT; TILLEMENT, FUNDAM. CLIN. PHARMACOL., (1999), vol. 13, pages 16 - 26
    - EMERICH, DF ET AL., CELL TRANSPLANT, (1999), vol. 8, pages 47 - 58
    - PROG NEUROPSYCHOPHARMACOL BIOL PSYCHIATRY, (1999), vol. 23, pages 941 - 949
    - BOADO, J. PHARM. SCI., (1998), vol. 87, pages 1308 - 1315
    - TYLER ET AL., FEBS LETT., (1999), vol. 421, pages 280 - 284
    - PARDRIDGE ET AL., PNAS USA., (1995), vol. 92, pages 5592 - 5596
    - BOADO, ADV. DRUG DELIVERY REV., (1995), vol. 15, pages 73 - 107
    - ALDRIAN-HERRADA ET AL., NUCLEIC ACIDS RES., (1998), vol. 26, pages 4910 - 4916
    - TYLER ET AL., PNAS USA, (1999), vol. 96, pages 7053 - 7058
    - LASIC ET AL., CHEM. REV., (1995), vol. 95, pages 2601 - 2627
    - ISHIWATA ET AL., CHEM. PHARM. BULL., (1995), vol. 43, pages 1005 - 1011
    - LASIC ET AL., SCIENCE, (1995), vol. 267, pages 1275 - 1276
    - OKU ET AL., BIOCHIM. BIOPHYS. ACTA, (1995), vol. 1238, pages 86 - 90
    - LIU ET AL., J. BIOL. CHEM., (1995), vol. 42, pages 24864 - 24870
    - WU; WU, J. BIOL. CHEM., (1987), vol. 262, pages 4429 - 4432
    - BAENZIGER; FIETE, CELL, (1980), vol. 22, pages 611 - 620
    - CONNOLLY ET AL., J. BIOL. CHEM., (1982), vol. 257, pages 939 - 945
    - LEE; LEE, GLYCOCONJUGATE J., (1987), vol. 4, pages 317 - 328
    - PONPIPOM ET AL., J. MED. CHEM., (1981), vol. 24, pages 1388 - 1395
    - IZANT; WEINTRAUB, SCIENCE, (1985), vol. 229, page 345
    - MCGARRY; LINDQUIST, PROC. NATL. ACAD. SCI., USA, (1986), vol. 83, page 399
    - SCANLON ET AL., PROC. NATL. ACAD. SCI. USA, (1991), vol. 88, pages 10591 - 5
    - KASHANI-SABET ET AL., ANTISENSE RES. DEV., (1992), vol. 2, pages 3 - 15
    - DROPULIC ET AL., J. VIROL., (1992), vol. 66, pages 1432 - 41
    - WEERASINGHE ET AL., J. VIROL., (1991), vol. 65, pages 5531 - 4
    - OJWANG ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 10802 - 6
    - CHEN ET AL., NUCLEIC ACIDS RES., (1992), vol. 20, pages 4581 - 9
    - SARVER ET AL., SCIENCE, (1990), vol. 247, pages 1222 - 1225
    - THOMPSON ET AL., NUCLEIC ACIDS RES., (1995), vol. 23, page 2259
    - GOOD ET AL., GENE THERAPY, (1997), vol. 4, page 45
    - OHKAWA ET AL., NUCLEIC ACIDS SYMP. SER., (1992), vol. 27, pages 15 - 6
    - TAIRA ET AL., NUCLEIC ACIDS RES., (1991), vol. 19, pages 5125 - 30
    - VENTURA ET AL., NUCLEIC ACIDS RES., (1993), vol. 21, pages 3249 - 55
    - CHOWRIRA ET AL., J. BIOL. CHEM., (1994), vol. 269, page 25856
    - COUTURE ET AL., TIG., (1996), vol. 12, page 510
    - ELROY-STEIN; MOSS, PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 6743 - 7
    - GAO; HUANG, NUCLEIC ACIDS RES., (1993), vol. 21, pages 2867 - 72
    - LIEBER ET AL., METHODS ENZYMOL., (1993), vol. 217, pages 47 - 66
    - ZHOU ET AL., MOL. CELL. BIOL., (1990), vol. 10, pages 4529 - 37
    - OJWANG ET AL., PROC. NATL. ACAD. SCI. U S A, (1992), vol. 89, pages 10802 - 6
    - YU ET AL., PROC. NATL. ACAD. SCI. U S A, (1993), vol. 90, pages 6340 - 4
    - L'HUILLIER, EMBO J., (1992), vol. 11, pages 4411 - 8
    - LISZIEWICZ ET AL., PROC. NATL. ACAD. SCI. U. S. A, (1993), vol. 90, pages 8000 - 4
    - SULLENGER; CECH, SCIENCE, (1993), vol. 262, page 1566
    - NOONBERG ET AL., NUCLEIC ACID RES., (1994), vol. 22, page 2830
    - GOOD ET AL., GENE THER., (1997), vol. 4, page 45
    - TUSCHL ET AL., GENES AND DEVELOPMENT, (1999), vol. 13, pages 3191 - 3197
    - ZAMORE ET AL., CELL, (2000), vol. 101, pages 25 - 33
    - ANDREWS; FALLER, NUCLEIC ACIDS RESEARCH, (1991), vol. 19, page 2499
    - PANDEY ET AL., SCIENCE, (1995), vol. 268, pages 567 - 569
    - PIERCE ET AL., PROC. NATL. ACAD. SCI. USA., (1995), vol. 92, pages 905 - 909
    - SHWEIKI ET AL., J. CLIN. INVEST., (1992), vol. 91, pages 2235 - 2243
    - BURGER ET AL., CORNEA, (1985), vol. 4, pages 35 - 41
    - LEPRI ET AL., J. OCULAR PHARMACOL., (1994), vol. 10, pages 273 - 280
    - ORMEROD ET AL., AM. J. PATHOL., (1990), vol. 137, pages 1243 - 1252
    - GRANT ET AL., DIABETOLOGIA, (1993), vol. 36, pages 282 - 291
    - ZIECHE ET AL., LAB. INVEST., (1992), vol. 67, pages 711 - 715
    - SHWEIKI ET AL., CLIN. INVEST., (1993), vol. 91, pages 2235 - 2243
    - O'REILLY ET AL., CELL, (1994), vol. 79, pages 315 - 328
    - SENGER ET AL., CANCER AND METAS. REV., (1993), vol. 12, pages 303 - 324
    - TAKAHASI ET AL., CANCER RES., (1994), vol. 54, pages 4233 - 4237
 US19980082404
 US20020362016
 US20020201394
 US20020402996
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.